Parallax Volatility Advisers’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Parallax Volatility Advisers's ARKG Position: Q1 2026 in Review
Parallax Volatility Advisers reduced its ARK Genomic Revolution ETF (ARKG) stake by 9.5% in Q1 2026, selling an estimated $58.5K and leaving 19,071 shares worth $586K. The position accounts for ﹤0.01% of the portfolio, ranked #1035.
Parallax Volatility Advisers first reported a position in ARKG in Q1 2022 and has held it in 17 quarters since. The position peaked at $5.37M in Q2 2022. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.
- Parallax Volatility Advisers held 19,071 shares of ARK Genomic Revolution ETF worth $586K as of Q1 2026.
- Parallax Volatility Advisers sold 1,998 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $58.5K.
- ARK Genomic Revolution ETF made up ﹤0.01% of Parallax Volatility Advisers's portfolio in Q1 2026, its #1035 holding.
- Parallax Volatility Advisers first reported a position in ARK Genomic Revolution ETF in Q1 2022 and has held it in 17 quarters since.
- Parallax Volatility Advisers's ARK Genomic Revolution ETF position peaked at $5.37M in Q2 2022.
- 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.
Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.